clinical trials

Protalix’ oral anti-TNF drug hits the mark in phase 2 ulcerative colitis trial
Protalix’ oral anti-TNF drug hits the mark in phase 2 ulcerative colitis trial
Fierce Biotech
Protalix
anti-TNF
clinical trials
ulcerative colitis
OPRX-106
Flag link:
Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca — biotech’s shares plunge
Patient death forces FDA to slap a hold on study using combo from Advaxis, AstraZeneca — biotech’s shares plunge
Endpoints
FDA
Advair
AstraZeneca
Imfinzi
clinical trials
Flag link:
Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale
Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale
Endpoints
Biogen
schizophrenia
clinical trials
Pfizer
PF-04958242
Flag link:
Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?
Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?
Yahoo/Reuters
Regeneron
Sanofi
Praluent
insurers
clinical trials
Flag link:
3 Things In Biotech, March 8: A Tale Of 3 New Trials
3 Things In Biotech, March 8: A Tale Of 3 New Trials
Seeking Alpha
biotech
clinical trials
Seattle Genetics
SGN-CD48A
Daiichi Sankyo
DS-8201
HER-positive colorectal cancer
Allena Pharmaceuticals
hyperoxaluria
Flag link:
Esperion's cholesterol drug succeeds in late-stage study
Esperion's cholesterol drug succeeds in late-stage study
Reuters
Esperion Therapeutics
clinical trials
bempedoic acid
cholesterol
Flag link:
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Failure in pivotal PhIII brain cancer trial drags Israel’s VBL Therapeutics down
Endpoints
clinical trials
VBL Therapeutics
VB-111
Roche
Avastin
glioblastoma
Flag link:
Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus
Deflating R&D claims, prosecutors say an impatient Martin Shkreli conducted bogus drug study in Cyprus
Endpoints
R&D
Martin Shkreli
RE-0024
Retrophin
Cyprus
clinical trials
Flag link:
Novartis joins forces with LA tech company Science 37 to launch virtual clinical trials
Novartis joins forces with LA tech company Science 37 to launch virtual clinical trials
Endpoints
Novartis
Science 37
clinical trials
virtual clinical trials
Flag link:
GlaxoSmithKline's Fluarix protects young children in large phase 3 test
GlaxoSmithKline's Fluarix protects young children in large phase 3 test
Fierce Pharma
GSK
Fluarix Tetra
clinical trials
pediatric
Flag link:
Shire's HAE candidate boosted by new Phase 3 data
Shire's HAE candidate boosted by new Phase 3 data
Biopharma Dive
Shire
HAE
clinical trials
lanadelumab
Flag link:
Clearside Biomedical shares soar after eye drug succeeds in Ph3 trial
Clearside Biomedical shares soar after eye drug succeeds in Ph3 trial
Drug Delivery Business News
Clearside Biomedical
clinical trials
CLS-TA
non-infectious uveitis
Flag link:
Roche, Ionis herald a big win in early-stage Huntington’s disease trial, demonstrate disease modifying potential
Roche, Ionis herald a big win in early-stage Huntington’s disease trial, demonstrate disease modifying potential
Endpoints
Roche
Ionis Pharmaceuticals
clinical trials
Huntington's disease
IONIS-HTT Rx
Flag link:
This could be the next $1 billion drug, if patients get on board
This could be the next $1 billion drug, if patients get on board
Yahoo/Marketwatch
sickle cell disease
Rivipansel
Pfizer
clinical trials
Flag link:
Lilly touts Ph3 data for once-weekly Type II diabetes medication
Lilly touts Ph3 data for once-weekly Type II diabetes medication
Drug Delivery Business News
Eli Lilly
diabetes
clinical trials
Trulicity
Flag link:
Beware the Lure of Early Clinical Trials Results: More Than a Third May be Exaggerated
Beware the Lure of Early Clinical Trials Results: More Than a Third May be Exaggerated
Xtalks
clinical trials
clinical trial data
Flag link:
Merck’s melanoma drug shows early promise for resistant cancers in PhI trial
Merck’s melanoma drug shows early promise for resistant cancers in PhI trial
Endpoints
Merck
melanoma
clinical trials
MK-8353
Flag link:
In a turf war with Eli Lilly, Novo Nordisk steps off with positive PhIII for its challenging oral GLP-1 drug
In a turf war with Eli Lilly, Novo Nordisk steps off with positive PhIII for its challenging oral GLP-1 drug
Endpoints
Novo Nordisk
Eli Lilly
diabetes
clinical trials
semaglutide
Trulicity
Flag link:
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
GW Pharma shares dented after cannabinoid drug fails a PhIIa study on focal seizures
Endpoints
GW Pharma
clinical trials
cannabinoids
Epidiolex
seizures
Flag link:
$690M deal in peril after Lilly ends mid-stage studies
$690M deal in peril after Lilly ends mid-stage studies
Biopharma Dive
Eli Lilly
clinical trials
rheumatoid arthritis
Btk inhibitors
Hanmi Pharmaceutical
LY3337641/HM71224
Flag link:

Pages